WO2000045391A1
(fr)
*
|
1999-01-29 |
2000-08-03 |
Sharper Image Corporation |
Porte-disques compacts
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US20030175346A1
(en)
*
|
2002-02-01 |
2003-09-18 |
Anne Billotte |
Osmotic delivery system
|
US6620900B2
(en)
*
|
2002-02-07 |
2003-09-16 |
Isp Investments Inc. |
Proliferous copolymer of vinyl pyrrolidone and vinyl acetate
|
US20070077301A1
(en)
*
|
2002-12-23 |
2007-04-05 |
Meyer Glenn A |
Venlafaxine osmotic device formulation
|
US8293799B2
(en)
*
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
WO2006070406A1
(fr)
*
|
2004-12-29 |
2006-07-06 |
J.B. Chemicals & Pharmaceuticals Ltd |
Comprimés bicouches d'oxcarbazépine à libération contrôlée et procédé de préparation de ceux-ci
|
EP1690540A1
(fr)
*
|
2005-02-15 |
2006-08-16 |
Neuro3D |
Composition comprenant l'ocapéridone
|
US8030260B2
(en)
|
2005-03-25 |
2011-10-04 |
Chemsil Silicones, Inc |
Pre-shave compositions and methods of using same
|
US7405186B2
(en)
*
|
2005-03-25 |
2008-07-29 |
Chemsil Silicones, Inc. |
Lubricant compositions, condom products and methods of making same
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
WO2007038619A2
(fr)
*
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Produits pharmaceutiques proteiques et utilisations de ceux-ci
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
EP1981525B1
(fr)
|
2005-12-30 |
2015-01-21 |
Zensun (Shanghai) Science and Technology Limited |
Liberation etendue de neureguline destinee a ameliorer la fonction cardiaque
|
AU2008287340A1
(en)
*
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|
US8372431B2
(en)
|
2007-10-26 |
2013-02-12 |
Bial-Portela & C.A., S.A. |
Pharmaceutical composition comprising licarbazepine acetate
|
EP2344138B1
(fr)
*
|
2008-09-25 |
2014-07-16 |
Basf Se |
Utilisation de copolymères à base de polyéthers et de monomères vinyliques en tant que liants pour des formes posologiques solides contenants des principes actifs
|
CA2748314C
(fr)
|
2009-02-03 |
2018-10-02 |
Amunix Operating Inc. |
Polypeptides recombinants etendus et compositions les comprenant
|
CA2764108A1
(fr)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Polypeptides de regulation du glucose et leurs procedes de production et d'utilisation
|
ES2643641T3
(es)
|
2009-06-08 |
2017-11-23 |
Amunix Operating Inc. |
Polipéptidos de hormona del crecimiento y métodos de producción y uso de los mismos
|
WO2011028229A1
(fr)
|
2009-08-24 |
2011-03-10 |
Amunix Operating Inc. |
Compositions de facteur ix de coagulation et leurs procédés de fabrication et d'utilisation
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
US20140302138A1
(en)
|
2011-10-14 |
2014-10-09 |
Micro Labs Limited |
Extended release pharmaceutical compositions containing carbamazepine
|
LT3564260T
(lt)
|
2012-02-15 |
2023-01-10 |
Bioverativ Therapeutics Inc. |
Viii faktoriaus kompozicijos ir jų gamybos bei panaudojimo būdai
|
CA2864126A1
(fr)
|
2012-02-15 |
2013-08-22 |
Biogen Idec Ma Inc. |
Proteines de facteur viii de recombinaison
|
EP2869911A4
(fr)
|
2012-07-09 |
2016-05-11 |
Fosmo Med Inc |
Dispositifs utilisant une osmose directe médiée par membrane
|
US9394327B1
(en)
*
|
2013-03-15 |
2016-07-19 |
The Trustees Of California State University |
Nucleoside crystals, crystal nucleation and growth control with antifreeze proteins
|
JP6041823B2
(ja)
|
2013-03-16 |
2016-12-14 |
ファイザー・インク |
トファシチニブの経口持続放出剤形
|
TW202003554A
(zh)
|
2013-08-14 |
2020-01-16 |
美商百歐維拉提夫治療公司 |
因子viii-xten融合物及其用途
|
EA201890423A1
(ru)
|
2015-08-03 |
2018-07-31 |
Биовератив Терапьютикс Инк. |
Слитые белки фактора ix, способы их получения и применения
|
JP2019519487A
(ja)
|
2016-05-05 |
2019-07-11 |
アクエスティブ セラピューティクス インコーポレイテッド |
送達増強エピネフリン組成物
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
CN108125922A
(zh)
*
|
2018-01-14 |
2018-06-08 |
上海安必生制药技术有限公司 |
一种卡马西平口服缓释制剂及其制备方法
|
SG11202010767SA
(en)
|
2018-05-18 |
2020-11-27 |
Bioverativ Therapeutics Inc |
Methods of treating hemophilia a
|